Actualités

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

Tesla's chief designer indicated that the repeatedly delayed electric sports car could finally be approaching its production-form debut.

AMD's four-part bond offering gives the chipmaker additional financial flexibility as it expands its artificial-intelligence infrastructure business.

Rising DRAM and NAND prices could amplify the earnings effect of Micron's rapidly expanding data-center demand.

Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing the first approved CELMoD therapy in this disease setting. See our latest analysis for Bristol-Myers Squibb. The ZENBEXUS approval lands at a time when Bristol-Myers Squibb’s momentum has picked up, with the share price at US$64.65 and a 30 day share price return of 13.52%. That builds on a 20.93% year to date share price return and a...

Red Cat stock soars as Trump announces aggressive tariffs on foreign drones. But Wall Street believes RCAT shares will rip higher through the remainder of 2026.

SanDisk, Pagaya, NeoVolta and Aeromexico offer 35%+ upside potential after strong Q2 results, with growth catalysts across key industries.

Unusual Machines stock soars as President Trump aggressively raises tariffs on foreign drones. But is it too late to invest in UMAC shares already?

Pershing Square believes Netflix's scale, advertising growth and expanding margins outweigh concerns about engagement and AI-generated content.

Almost every ETF claiming to own Dividend Aristocrats actually mixes in other holdings, but a small group of funds holds nothing but these elite dividend growers. Choosing the wrong one in 2026 could cost you years of compounding.

Record revenue, a guide above Wall Street, and a stock down anyway, because the growth now arrives as hardware and the mix shift is what compresses the margin.

“Boomer candy” funds got the name because they appeal to retirees. Goldman Sachs sees opportunity and acquires ETF company Neos.

Joining the benchmark should create compulsory demand from passive funds while placing Reddit beside America's largest public companies.

In the past week, Nebius Group reported second-quarter 2026 results showing revenue of US$582.3 million, with its AI cloud business driving very large year-on-year growth through four AI infrastructure contracts each exceeding US$1 billion in total value and a higher contracted power target of 5 gigawatts. Alongside this earnings release, Nebius’s deepening relationship with NVIDIA and rapid UK data center expansion, including new capacity at Vantage’s CWL1 campus in South Wales, underline...

Two AI chip giants moved in opposite directions Friday as Wall Street put a massive dollar figure on a financing structure that Broadcom and Nvidia both use, raising questions about which companies benefit from AI's debt-fueled buildout and which carry the hidden risk.

Semiconductors are the picks and shovels of modern technology. The way we live and work is also changing with AI, which is creating secular demand for more powerful chips. As a result, the industry has seen solid stock price performance over the last six months as its gain of 46.5% has outpaced the S&P 500’s 13.5% return.

Three Pfizer insiders executed transactions directly on the heels of the drugmaker’s second-quarter earnings report.

The stock market rally shows several stocks in extended positions. Four stocks near new highs and buy points are on watch.

Internet Software & Services benefits from digitalization and AI, though disruption and competition temper the outlook. Buy VRSN.

A federal appeals court ruled Thursday that international versions of Gilead's HIV drug Biktarvy differ materially from FDA-regulated U.S. versions

Shares of cybersecurity products maker Mitek are recovering from a tumble in July. Mitek's sales are up as customers fight AI-driven fraud.

Oracle'sstock chart looks like a horror movie right now, and the plot keeps getting scarier. Shares of Oracle (ORCL) have fallen almost 50% from its September 2025 peak and are down 20% year-to-date. The recent sell-off is driven by a credit downgrade, a spike in bond insurance costs, and ...

Wall Street Lifts Sandisk Stock Outlook: $2,250 Target Puts Shares in Focus

Memory has always been the worst business in semiconductors, so when a top analyst says one company can hand back its entire market cap in buybacks, skepticism is the natural response. But the math and the contracts behind this claim deserve a much harder look.

Trump just signed a proclamation slapping steep tariffs on imported drones, and the winners inside the sector are not who most investors expected. Here is why the reaction splits so sharply across the group.

Investing.com -- Bernstein upgraded Wayfair to Outperform from Market-Perform and raised its price target to $125 from $100, citing stronger revenue growth and improving operating leverage following the company's second-quarter results.

Furniture retailers have spent years waiting for the housing market to revive demand for sofas, beds, and other big-ticket home purchases. That rebound remains elusive, but some of the industry's biggest players are finding growth anyway. Wayfair reported second-quarter net revenue of $3.5 billion, ...

ANI Pharmaceuticals' low valuation and strong 2026 growth outlook face a key test as Cortrophin execution risk rises.

Bill Ackman's Pershing Square Holdings has taken a stake in Netflix after having previously exited the streamer in 2022. You, too, should add NFLX stock given its tepid valuation.

The AI revolution and robust earnings growth are just two of several catalysts that could drive stocks higher for the rest of 2026. Kevin Matras can help position you to capitalize on a fourth straight year of double-digit gains that might eclipse 30%.